Even in cases with no obvious PTL inflammation, the higher the number of CD8+, FOXp3+ and CD68+ cells relative to the number of tumor buds (ratio of immune cells-defenders /tumor budding cells-attackers), the more favorable the impact on patient survival [72]. The gene discussed is FOXP3; the disease is neoplasm.